Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Many factors can contribute to tablet manufacturing problems. Tablet tooling failures are generally the result of one, or a combination of issues.

Seven Steps to Solving Tabletting and Tooling Problems—Step 1: Clean

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

The divestment will create the number two player in the global influenza vaccine industry.

Novartis Sells Influenza Vaccine Business to CSL for $275 Million

GSK's investigational Ebola vaccine is in Phase I safety trials.

GSK Accelerates Ebola Vaccine Development

Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.

J&J Speeds Ebola Vaccine Development and Expands Production

Contract Packaging Resources issued a voluntary recall of naproxen sodium tablets because some cartons contain bottles of ibuprofen.

Drug Repackaging Company Recalls Tablets Due to Packaging Mix-Up

The agency recommends that companies developing drugs to treat Ebola apply for orphan drug designation.

EMA Works to Speed Up Ebola Treatment

PharmaSpray delivers a consistent, validatable amount of dry lubricant.

External Lubrication System Enhances Tablet Press Performance

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Manufacturers using highly potent APIs must examine cross-contamination routes and determine acceptable limits.

Evaluating Cross-Contamination Risk of Highly Potent APIs

IDT Biologika completes large-scale biologics finishing facility in Dessau, Germany.

IDT Biologika Certifies Facility to Fill and Lyophilize Biologics and Vaccines

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The total market for biopharmaceuticals in 2013 was $36.8 billion according to Kalorama Information. Meanwhile, Frost & Sullivan estimates that the biosimilars market, which it pegged at just $1.2 billion in 2013, will grow to $23 billion in 2019, or more than 20-fold increase.